{"id":452760,"date":"2025-10-10T14:57:12","date_gmt":"2025-10-10T14:57:12","guid":{"rendered":"https:\/\/www.europesays.com\/fr\/452760\/"},"modified":"2025-10-10T14:57:12","modified_gmt":"2025-10-10T14:57:12","slug":"lavenir-de-lentreprise-est-scelle","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/fr\/452760\/","title":{"rendered":"l&rsquo;avenir de l&rsquo;entreprise est scell\u00e9"},"content":{"rendered":"<p>                            <strong>Alors que l\u2019Assembl\u00e9e g\u00e9n\u00e9rale de la biotech OSE Immunotherapeutics s\u2019est d\u00e9roul\u00e9 le 30 septembre dernier sous haute tension, l\u2019avenir de la soci\u00e9t\u00e9 a \u00e9t\u00e9 scell\u00e9 par les actionnaires.<\/strong><\/p>\n<p class=\"p1\">Une date qui \u00e9tait tr\u00e8s attendue comme redout\u00e9e. L\u2019assembl\u00e9e g\u00e9n\u00e9rale d\u2019OSE Immunotherapeutics la biotech nantaise, s\u2019est tenue le 30 septembre dernier et scell\u00e9 l\u2019avenir de la soci\u00e9t\u00e9 brillante, <strong><a href=\"https:\/\/hellogazettenantes.fr\/ose-immunotherapeutics-quest-il-arrive-a-la-biotech-nantaise\/\" rel=\"nofollow noopener\" target=\"_blank\">mais affaiblie par une crise interne<\/a><\/strong>. Une assembl\u00e9e sous tr\u00e8s haute tension donc, avec pour rappel, des d\u00e9saccords qui persistaient sur la strat\u00e9gie de l\u2019entreprise qui ne cesse de s\u2019imposer dans le domaine de la recherche m\u00e9dicale. Par voie de communiqu\u00e9 de presse OSE immoth\u00e9rapeutics vient d\u2019annoncer le renouvellement complet du Conseil d\u2019Administration, la nomination du Dr Markus Cappel en tant que Pr\u00e9sident du Conseil d\u2019administration et de Marc le Bozec comme Directeur G\u00e9n\u00e9ral par interim.<\/p>\n<p><strong>L\u2019ancien Directeur G\u00e9n\u00e9ral Nicolas Poirier conserve son poste de Directeur Scientifique\u00a0<\/strong><\/p>\n<p class=\"p1\">Pr\u00e9sent\u00e9 par la biotech comme une personnalit\u00e9 ayant \u00ab\u00a0une grande exp\u00e9rience du management de transition\u00a0\u00bb Marc Le Bozec tient \u00ab\u00a0\u00e0 rassurer les \u00e9quipes, dont nous connaissons le talent, leur donner une direction claire, tout en maintenant l\u2019innovation th\u00e9rapeutique au coeur de la soci\u00e9t\u00e9\u00a0\u00bb s\u2019est t-il \u00e9galement exprim\u00e9. Et cela n\u2019a pas \u00e9t\u00e9 suffisant pour Nicolas Poirier. L\u2019ancien Directeur G\u00e9n\u00e9ral qui vient d\u2019\u00eatre r\u00e9voqu\u00e9 par l\u2019Assembl\u00e9e g\u00e9n\u00e9rale\u00a0 \u00ab\u00a0conserve son poste de Directeur scientifique chez OSE\u00a0\u00bb conclut l\u2019entreprise.<\/p>\n<p><img decoding=\"async\" alt=\"Advertisement\" src=\"data:image\/svg+xml,%3Csvg%20xmlns=\" http:=\"\" data-lazy-src=\"https:\/\/www.europesays.com\/fr\/wp-content\/uploads\/2025\/04\/Application-mobile-hello-gazette-nantes.gif\"\/><\/p>\n","protected":false},"excerpt":{"rendered":"Alors que l\u2019Assembl\u00e9e g\u00e9n\u00e9rale de la biotech OSE Immunotherapeutics s\u2019est d\u00e9roul\u00e9 le 30 septembre dernier sous haute tension,&hellip;\n","protected":false},"author":2,"featured_media":452761,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2818],"tags":[1111,11,1777,674,1011,27,766,12,2636,25],"class_list":{"0":"post-452760","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-nantes","8":"tag-actu","9":"tag-actualites","10":"tag-eu","11":"tag-europe","12":"tag-fr","13":"tag-france","14":"tag-nantes","15":"tag-news","16":"tag-pays-de-la-loire","17":"tag-republique-francaise"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@fr\/115350460469925749","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/452760","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/comments?post=452760"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/posts\/452760\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media\/452761"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/media?parent=452760"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/categories?post=452760"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/fr\/wp-json\/wp\/v2\/tags?post=452760"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}